期刊文献+

荧光原位杂交技术在血尿患者膀胱尿路上皮癌筛查中的应用 被引量:5

Detection of bladder cancer from the urine using fluorescence in situ hybridization(FISH)technique
下载PDF
导出
摘要 目的评价荧光原位杂交(fluorescence in situ hybridization,FISH)技术在血尿患者膀胱尿路上皮癌筛查中的临床应用价值,为从尿液脱落细胞中早期诊断膀胱癌提供新的途径。方法选择20例健康正常人,通过FISH技术检测9号染色体p16位点、3号染色体、7号染色体及17号染色体变异情况,建立阈值。100例血尿患者留取晨尿,分别进行尿脱落细胞学检查和FISH技术检查。统计分析FISH方法的敏感度和特异度。结果探针检测p16基因完全缺失阈值为3.9%,部分缺失为5.4%,扩增为3.2%;3号染色体缺失阈值为4.0%,扩增为3.5%;7号染色体缺失阈值为4.0%,扩增为2.8%;17号染色体缺失阈值为5.8%,扩增为3.4%。以至少两种探针检测结果超过阈值或一种探针检测结果至少存在两种异常为诊断阳性。FISH技术在血尿患者膀胱尿路上皮癌筛查中的敏感度和特异度分别为93.6%和100%,尿脱落细胞学检测分别为46.8%和100%。结论 FISH技术无创快速,对血尿患者膀胱尿路上皮癌筛查的敏感度优于尿脱落细胞学检查方法。 Objective To evaluate the clinical significance of fluorescence in situ hybridization (FISH) technique for screening bladder transitional cell carcinoma with hematuria, provide a new method for early diagnosis of bladder cancer with cytology of the urine. Methods We selected 20 relatively healthy people as control group. The special urine examination method detects genetic al- terations of the urothelial cells found in the urine of the control group, using fluorescent direct la- beled DNA probes binding to the peri-centromeric regions of chromosomes 3, 7 and 17 as well as on the 9p21 locus, respectively. Thresholds were then established. Morning urine samples collecting from 100 patients with hematuria underwent cytology of the urine and FISH examination, respectively. The sensitivity and specificity of both were analyzed statistically. Results The complete absent, the partial absent and amplification thresholds for p16 gene detected by probes were 3.9%, 5. 4% and 3.2%, respectively. The absent and amplification thresholds for chromosome 3 were 4.0% and 3.5 %; 4.0 %and 2.8% for chromosome 7 ; 5.8 %fro and 3.4 %for chromosome 17 respectively. The study rated the specificity and sensitivity of the technique 93.6% and 100%, respectively. The study rated the specificity and sensitivity of the urinary exfoliative cytology 46.8% and 100%, respectively. Conclusions This new non-invasive diagnostic application of the FISH technique with high detection rate in the field of urology is prior to urinary cytology.
出处 《现代泌尿生殖肿瘤杂志》 2010年第6期328-331,共4页 Journal of Contemporary Urologic and Reproductive Oncology
基金 卫生部科研基金课题子课题(WKJ-3-001) 安徽省科技厅科研基金项目(08020303084)
关键词 膀胱肿瘤 荧光原位杂交技术 脱落细胞学 Urinary bladder neoplasms Fluorescence in situ hybridization Cytology
  • 相关文献

参考文献11

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J C1in,2005,55(2):74-108.
  • 2Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J C1in,2008,58(2):71-96.
  • 3Hailing KC,King W,Sokolova IA,et al.A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma[J].J Urol,2000,164(5):1768-1775.
  • 4Sokolova IA,Hailing KC,Jenkins RB,et al.The development of a multitarget,muhicolor fluotescence in situ hybridization assay for the dectection of urothelial carcinoma in ufine[J].J Mol Diagn,2000,2(3):116-123.
  • 5Constantinou M,Binka-Kowalska A,Borkowska E,et al.Application of multiplex FISH,CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens[J].J Appl Genet,2006,47(3):273-275.
  • 6Yoder BJ,Skacel M,Hedgepeth R,et al.Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology:a prospective study with focus on the natural history of anticipatory positive findings[J].Am J Clin Pathol,2007,127(2):295-301.
  • 7Sarosdy MF,Kahn PR,Ziffer MD,et al.Evaluation of a multi-target fluorescent in-situ hybridization (FISH) assay in the initial diagnosis of bladder cancer in patients with hematuria[J].J Urol,2004,171(suppl):66.
  • 8Riesz P,Lotz G,Paska C,et al.Detection of bladder cancer from the urine using fluorescence in situ hybridization technique[J].Pathol Oncol Res,2007,13(3):187-194.
  • 9Skacel M,Fahmy M,Brainard JA,et al.Muhitarget fluorescence in situ hybridization assay dectects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology[J].J Urol,2003,169(6):2101-2105.
  • 10Raitanen MP,Kaasinen E,Lukkafinen O,et al.Analysis of false-positive BAT STAT test results in patients followed up for bladder cancer[J].Urology,2001,57(4):680-684.

同被引文献38

  • 1张绍谨,刘红耀.尿膀胱癌抗原、核基质蛋白22和透明质酸诊断膀胱癌的临床价值[J].中华临床医师杂志(电子版),2011,5(24):7202-7205. 被引量:15
  • 2曾辉,林僖,陈孝岳,刘隆忠,赵雁梨.经直肠或经阴道腔内超声在膀胱癌术前分期中的应用价值[J].中华泌尿外科杂志,2005,26(2):135-135. 被引量:14
  • 3Planz B, Jochims E, Deix T, et al. The role of urinary cytol- ogy for detection of bladder cancer[J]. Eur J Surg Oncol, 2005,31 (3) z 304-308.
  • 4Luo B, Li W, Deng CH, et al. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma[J]. Cancer Genet Cytogenet,2009,189(2) ..93-97.
  • 5Song MJ, Lee HM, Kim SH. Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer [J]. Cancer Genet Cytogenet, 2010,198(2) : 144-150.
  • 6Sarosdy MF, Kahn PR, Ziffer MD, et al. Use of a multitar- get fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria[J]. J Urol, 2006,176 (1) : 44-47.
  • 7Jones JS. DNA-based molecular cytology for bladder cancer surveillance[J]. Urology,2006,67(3 Suppl 1) :35-45.
  • 8Degtyar P, Neulander E, Zirkin H, et al. Fluorescence in si tu hybridization performed on exfoliated urothelial cells in pa tients with transitional cell carcinoma of the bladder[J]. U rology,2004,63 (2) : 398-401.
  • 9Moonen PM, Merkx GF, Peelen P, et al. UroVysion com pared with cytology and quantitative cytology in the surveil lance of non-muscle invasive bladder cancer[J]. Eur Urol 2007,51(5) :1275-1280.
  • 10Laudadio J, Keane TE, Reeves HM, et al. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for climc, al .practice [J ]. BJU Int, 2005,96 (9) 1280-1285.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部